JOTROL
Phase 2- Indications
- Mucopolysaccharidoses Type 1, Friedreich's Ataxia, MELAS, Mild Cognitive Impairment, Early Alzheimer's Disease
Company intelligence / Profile preview
Gene Spotlight
Miami, Florida, United Statesgenespotlight.org ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
"Gene Spotlight is a nonprofit medical research and advocacy organization focused on funding and supporting breakthroughs in treatments and cures for rare genetic disorders, including lysosomal storage diseases, uncommon cancers, and other orphan diseases. The organization provides grants to accelerate research but does not itself conduct clinical trials or develop therapeutics."[1][2]
- Therapeutic areas
- OncologyRare Diseases
- Industry
- Academic Hospital/University/Research
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Gene Spotlight.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gene Spotlight.